Related Experiment Video

Updated: Jun 22, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP

Xiaodong Ding1, Matthew S Goldberg

  • 1Department of Neurology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

Plos One
|June 19, 2009
PubMed

Insights

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause Parkinson's disease (PD). Researchers found CHIP protein regulates LRRK2 stability through ubiquitination and degradation, offering new therapeutic targets for PD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Dominantly inherited mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary genetic cause of Parkinson's disease (PD).
  • LRRK2's precise cellular role is undetermined, but PD-associated mutations often lead to cellular toxicity.
  • Mechanisms of LRRK2 toxicity involve its kinase activity or the formation of cellular inclusions.

Purpose of the Study:

  • To investigate the cellular regulation of leucine-rich repeat kinase 2 (LRRK2) stability.
  • To identify proteins that interact with LRRK2 and influence its abundance.
  • To explore potential therapeutic strategies for Parkinson's disease by targeting LRRK2 regulation.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions between LRRK2 and CHIP.
  • Western blotting to assess LRRK2 protein levels in cells.
  • Ubiquitination assays and proteasome inhibition to determine degradation pathways.
  • Treatment with Hsp90 inhibitor geldanamycin to assess its effect on LRRK2 stability.

Main Results:

  • The E3 ubiquitin ligase CHIP physically associates with LRRK2.
  • CHIP regulates the cellular abundance of LRRK2 through ubiquitination and proteasome-dependent degradation.
  • LRRK2 forms a complex with CHIP and heat shock protein 90 (Hsp90).
  • Hsp90 can reduce CHIP-mediated LRRK2 degradation, an effect blocked by geldanamycin.

Conclusions:

  • CHIP acts as a key regulator of LRRK2 stability by promoting its degradation.
  • Hsp90 modulates CHIP-LRRK2 interactions, influencing LRRK2 degradation.
  • Understanding LRRK2 regulation by CHIP and Hsp90 offers novel therapeutic avenues for Parkinson's disease.

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...